Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial

AIMS: Therapy with i.v. iron in patients with chronic heart failure (CHF) and iron deficiency (ID) improves symptoms, functional capacity, and quality of life. We sought to investigate whether these beneficial outcomes are independent of anaemia. METHODS AND RESULTS: FAIR-HF randomized 459 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Gerasimos, Farmakis, Dimitrios, Colet, Josep Comin, Dickstein, Kenneth, Lüscher, Thomas F., Willenheimer, Ronnie, Parissis, John, Gaudesius, Giedrius, Mori, Claudio, von Eisenhart Rothe, Barbara, Greenlaw, Nicola, Ford, Ian, Ponikowski, Piotr, Anker, Stefan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Comorbidity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806282/
https://www.ncbi.nlm.nih.gov/pubmed/23787722
http://dx.doi.org/10.1093/eurjhf/hft099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806282/
https://www.ncbi.nlm.nih.gov/pubmed/23787722
http://dx.doi.org/10.1093/eurjhf/hft099

Ejemplares similares